TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10 2023 - 4:05PM
TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage
medical technology company focused on providing innovative
soft-tissue reconstruction solutions that optimize clinical
outcomes by prioritizing the preservation and restoration of the
patient's own anatomy, today announced that the Compensation
Committee of the Board of Directors of TELA Bio approved inducement
grants of restricted stock units covering 40,700 shares of its
common stock to thirty-one newly-hired employees, with a grant date
of November 6, 2023 (the "Grant Date"). The restricted stock units
were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement
grant exception as a component of each individual's employment
compensation and were granted as an inducement material to his or
her acceptance of employment with TELA Bio.
The restricted stock units will vest in equal
annual installments over four years, subject to each individual's
continued service with TELA Bio through the applicable vesting
dates.
About TELA
Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage
medical technology company focused on providing innovative
technologies that optimize clinical outcomes by prioritizing the
preservation and restoration of the patient's own anatomy. The
Company is committed to providing surgeons with advanced,
economically effective soft-tissue reconstruction solutions that
leverage the patient's natural healing response while minimizing
long-term exposure to permanent synthetic materials. For more
information, visit www.telabio.com.
Caution Regarding
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of The Private Securities Litigation
Reform Act of 1995. Words such as "may," "might," "will," "should,"
"believe," "expect," "anticipate," "estimate," "continue,"
"predict," "forecast," "project," "plan," "intend" or similar
expressions, or statements regarding intent, belief, or current
expectations are forward-looking statements and reflect the current
beliefs of TELA Bio's management. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and other factors that could cause actual results and
events to differ materially and adversely from those indicated by
such forward-looking statements. These risks and uncertainties are
described more fully in the "Risk Factors" section and elsewhere in
our filings with the Securities and Exchange Commission and
available at www.sec.gov, including in our Annual Report on Form
10-K and Quarterly Reports on Form 10-Q. Any forward-looking
statements that we make in this announcement speak only as of the
date of this press release, and TELA Bio assumes no obligation to
update forward-looking statements whether as a result of new
information, future events or otherwise after the date of this
press release, except as required under applicable law.
Investor Contact
Greg Chodaczek332-895-3230ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024